Fasudil Hydrochloride Clinical Trials

2 actively recruiting trials

No change since May 2026

Also known as: Fasudil hydrochloride (Fasudil)

Pipeline

Phase 2: 2

Top Sponsors

Zhejiang Provincial People's Hospital1
Technical University of Munich1

Indications

Idiopathic Parkinson´s Disease1
Parkinson's Disease1
Ovarian Cancer1
Cancer1

Other2 trials

A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian Cancer

Phase 2

Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.